Western Blot Equipment and Supplies
Abcam Human SFRP1 knockout A549 cell line
Human SFRP1 knockout A549 cell line
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human STK24 knockout A-431 cell line
Human STK24 knockout A-431 cell line
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human KRT13 knockout A-431 cell line
Human KRT13 knockout A-431 cell line
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human LYZ (Lysozyme) knockout THP-1 cell line
Human LYZ (Lysozyme) knockout THP-1 cell line
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human DDIT3 knockout SW480 cell line
Human DDIT3 knockout SW480 cell line
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human TNC (Tenascin C) knockout U-2 OS cell line
Human TNC (Tenascin C) knockout U-2 OS cell line
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human NT5E knockout A-431 cell line
Human NT5E knockout A-431 cell line
The product is subject to the following: Abcam Restricted Use Statement
Abcam 7-Metho x y-4-(trifluoromethyl)coumarin, Fluorescent substrate for o x idoreductases, 50MG
MW 244.17 g/mol, Purity >99%. Fluorescent substrate for oxidoreductases, especially for Cytochrome P450.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mepyramine maleate, H1 inverse agonist, 100MG
MW 401.46 g/mol, Purity >99%. Selective H₁ receptor inverse agonist (Ki = 0.4 nM). Blood-brain barrier permeable. Shows antihistaminergic action. Additionally, inhibits histamine-induced inositol phosphate production and intracellular calcium mobilization.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mecamylamine hydrochloride, non-competitive antagonist of nicotinic receptors, 50MG
MW 203.75 Da. Non-competitive, non-selective antagonist of nicotinic actelycholine receptors (nAChRs). Blood-brain barrier permeable. Blocks various different nAChR types, (IC₅₀ values are 640 nM, 2.5 μM, 3.6 μM and 6.9 μM at α3β4, α4β2, α3β2 and α7 receptors, respectively). Blocks most physiological, behavioural and reinforcing effects of nicotine. Displays antidepressant-like effects in mice.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Iniparib, modifier of cysteine-containing proteins.
Iniparib, modifier of cysteine-containing proteins.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human H1F0 knockout A-431 cell line
Human H1F0 knockout A-431 cell line
The product is subject to the following: Abcam Restricted Use Statement